Pure red cell aplasia - A rare disease with multiple causes

Biomedicine and Pharmacotherapy

Volumn 57, Issue 8, 2003, Pages 326-332

  Djaldetti, M ^a,b   Blay, A ^c   Bergman, M ^b   Salman, H ^b   Bessler, H ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c TEVA PHARMACEUTICALS   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIBODY; CARBAMAZEPINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOXORUBICIN; ERYTHROPOIETIN; FLUDARABINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 3; LAMIVUDINE; LINEZOLID; METHYLPREDNISOLONE; METOCLOPRAMIDE; PHENYTOIN; PREDNISONE; RECOMBINANT ERYTHROPOIETIN; RIFAMPICIN; RITUXIMAB; THYMOCYTE ANTIBODY; VINCRISTINE;

AUTOIMMUNITY; B CELL LYMPHOMA; BLACKFAN DIAMOND ANEMIA; BLOOD GROUP ABO INCOMPATIBILITY; BONE MARROW; CLINICAL FEATURE; COLLAGEN DISEASE; CONGENITAL HYPOPLASTIC ANEMIA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MEGADOSE; ERYTHROBLAST; FLU LIKE SYNDROME; HEADACHE; HEMATOPOIESIS; HUMAN; HYPERTENSION; IDIOPATHIC DISEASE; LYMPHOPROLIFERATIVE DISEASE; MYELOPROLIFERATIVE DISORDER; NONHODGKIN LYMPHOMA; NONHUMAN; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PURE RED CELL ANEMIA; REVIEW; STEM CELL TRANSPLANTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; THYMECTOMY; VIRUS INFECTION;

EID: 0141892774     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2003.08.001     Document Type: Short Survey

References (72)

1. Abkowitz J.L., Schaison G., Boulad F., et al. Response of Diamond-Blackfan anemia to metoclorpramide: evidence for a role for prolactin in erythropoiesis. Blood. 100:2002;2687-2691.
2. Auner H.W., Wolfler A., Beham-Schmid C., et al. Restoration of erythropoiesis by rituximab in an adult patient with primary acquired pure red cell aplasia refractory to conventional treatment. Br J Haematol. 116:2002;727-728.
3. Bolan C.D., Leitman S.F., Griffith L.M., et al. Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative haematopoietic stem cell transplantation. Blood. 98:2001;1687-1694.
4. Bun H.F. Drug-Induced autoimmune red cell aplasia. New Engl J M. 346:2002;522-523.
5. Casadevall N. Antibodies against rHuEPO: native and recombinant. Nephrol Dial Transplant. 17:(Suppl 5):2002;42-47.
6. Casadevall N., Croisille L. Erythropoiesis disorders and other central autoimmune anemias. Rev Prat. 51:2001;1547-1551.
7. Casadevall N., Dupui E., Molho-Sabatier P., et al. Brief report: autoantibodies against erythropoietin in a patient with pure red cell aplasia. New Engl J M. 334:1996;630-633.
8. Casadevall N., Nataf J., Viron B., et al. Pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. New Engl J M. 346:2002;469-475.
9. Castelli R., Vismara A., Pavia G., et al. Relapsing pure red cell aplasia associated with B-cell chronic lymphocytic leukemia successfully treated by intravenous immunoglobulin concentrate. Ann Ital Med Int. 17:2002;9-10.
10. Chandra S.C., Ramana R.V., Srinivas B., et al. Pure red cell aplasia associated with carbazepine. J Assoc Physicians India. 46:1998;655-656.
11. Choi B.G., Yoo W.H. Successful treatment of pure red cell aplasia with plasmapheresis in a patient with systemic lupus erythematosus. Yonsei Med J. 43:2002;274-278.
12. Dessypris E.N. Pure red cell aplasia. 3rd Hoffman R., et al. Hematology. Basic Principles and Practice. 2000;342-354 Churchill Livingstone, New York.
13. De-Vetten M.P., van-Gelder M., de-Greef G.E. Recovery of erythropoiesis following bone marrow transplantation for chronic lymphocytic leukaemia-associated pure red cell aplasia. Bone Marrow Transplant. 27:2001;771-773.
14. Dincol G., Aktan M., Nalcaci M., et al. Clonality of pure red cell aplasia: effectiveness of antithymocyte globulin. Leuk Lymphoma. 42:2001;1413-1417.
15. El-Beshlawy A., Ibrahim I.Y., Rizk S., et al. Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results. Pediatrics. 110:2002;e44.
16. Ergas D., Tsimanis A., Shtalrid M., et al. T-gamma large granular lymphocyte leukemia associated with amegakaryocytic purpura, Sjogren's syndrome, and polyglandular autoimmune syndrome type II, with subsequent development of pure red cell aplasia. Am J Hermatol. 69:2002;132-134.
17. Fujisawa S., Maruta A., Sakai R., et al. Pure red cell aplasia after major ABO-incompatible bone marrow transplantation: two case reports of treatment with recombinant human erythropoietin. Transplant Int. 9:1996;506-508.
18. Geetha D., Zachary J.B., Baldado H.M., et al. Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature. Clin Transplant. 14:2000;586-591.
19. Geller G., Drivit W., Zalusky R., et al. Lack of erythropoietic inhibitory effect of serum from patients with congenital pure red cell aplasia. New Engl J M. 292:1975;198-201.
20. Gershon S.K., Luksenburg H., Cote T.R., et al. Pure red cell aplasia and recombinant erythropoietin. New Engl J M. 2002;346-347.
21. Ghasal H. Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia. Blood. 99:2002;1092-1094.
22. Go R.S., Li C.Y., Tefferi A., et al. Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes. Blood. 98:2001;483-485.
23. Grigg A.P., O'Flaherty E. Cyclosporin A for the treatment of pure red cell aplasia associated with myelodysplasia. Leuk Lymphoma. 42:2001;1339-1342.
24. Habib G.S., Saliba W.R., Froom P. Pure red cell aplasia and lupus. Semin Arthritis Rheum. 31:2002;279-283.
25. Hamaguchi I., Ooka A., Brun A., et al. Gene transfer improves erythroid development in ribosomal protein S19-deficient Diamond-Blackfan syndrome. Blood. 100:2002;2724-2731.
26. Hirri H.M., Green P.J. Pure red cell aplasia in a patient with chronic granulocytic leukaemia treated with interferon-alpha. Clin Lab Haematol. 22:2000;53-54.
27. Kadikoylu G., Bolaman Z., Barutka S. High-dose methylprednisolone therapy in pure red cell aplasia. Ann Pharmacother. 36:2002;55-58.
28. Katayama H., Takeuchi M., Yoshino T., et al. Epstein-Barr virus associated diffuse large B-cell lymphoma complicated by autoimmune hemolytic anemia and pure red cell aplasia. Leuk Lymphoma. 42:2001;539-542.
29. Kiykim A.A., Arici M., Altun B., et al. Pure red cell aplasia preceding malignant lymphoma in a renal transplant patient. Nephron. 92:2002;232-234.
30. Koduri P.R. Parvovirus B19-related anemia in HIV-infected patients. AIDS Patient Care. 1:2000;7-11.
31. Kondo H., Mori A., Watanabe J., et al. Pure red cell aplasia associated with parvovirus B19 infection in T-large granular lymphocyte leukemia. Leuk Lymphoma. 42:2001;1439-1443.
32. Krantz S.B. Pure red cell aplasia. Br J Haematol. 25:1973;1-6.
33. Krantz S.B. Pure red cell aplasia. New Engl J M. 291:1974;3450-3450.
34. Lahiri T.K., Agrawal D., Agrawal K., et al. Pure red cell aplasia associated with thymoma. Indian J Chest Dis Allied Sci. 44:2002;259-262.
35. Larroche C., Mouthon L., Casadevall N., et al. Successful treatment of thymoma-associated pure red cell aplasia with intravenous immunoglobulins. Eur J Haematol. 65:2000;74-76.
36. Lee G.R., Bithel T.C., Foerster J., et al. Wintrobe's Clinical Hematology. 10th ed. Philadelphia: Lea & Febiger; 1999. p. 1474-84.
37. Lee J.H., Lee K.H., Kim S., et al. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation. Bone Marrow Transplant. 25:2000;179-184.
38. Linardaki G.D., Boki K.A., Fertakis A., et al. Pure red cell aplasia as presentation of systemic lupus erythematosus: antibodies to erythropoietin. Scand J Rheumatol. 28:1999;189-191.
39. Majluf-Gruz A., Luna-Castanos G., Trevino-Perez S., et al. Lamivudine-induced pure red cell aplasia. Am J Hematol. 65:2000;189-191.
40. Marmont A.M. Erythropoietin: biochemical characteristics, biological effects, indications and results of use in hematology. Tumori. 83:(4 Suppl 2):1997;S3-S15.
41. Martelli M., Ponchio L., Beguin Y., et al. Pure red cell aplasia following peripheral stem cell transplantation: complete response to a short course of high-dose recombinant human erythropoietin. Haematologica. 79:1994;456-459.
42. Marwaha R.K., Bansal D., Trehan A., et al. Clinico-haematological profile of pure red cell aplasia in children. J Trop Pediatr. 48:2002;113-116.
43. Maschan A.A., Skorobogatova E.V., Balashov D.N., et al. Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia. Bone Marrow Transplant. 6:2002;405-407.
44. Matsuhashi Y., Tasaka T., Uehara E., et al. Successful therapy of pure red cell aplasia secondary to plasma cell dyscrasia with bolus methylprednisolone. Intern M. 40:2001;802-804.
45. McGuire W.A., Yang H.H., Bruno E., et al. Treatment of antibody-mediated pure red cell aplasia with high-dose intravenous gamma globulin. New Engl J M. 317:1987;1004-1008.
46. Monson-Thomas, Schichman-Steven A., Zent-Clive S. Linezolid-induced pure red blood cell aplasia. Clin Infect Dis. 35:2002;E29-E31.
47. Miyoshi I., Hikita T., Koi B., et al. Reversible pure red cell aplasia in pregnancy. New Engl J M. 299:1978;777.
48. Murakawa T., Nakajima J., Sato H., et al. Thymoma associated with pure red cell aplasia: clinical features and prognosis. Asian Cardiovasc Thorac Ann. 10:2002;150-154.
49. Ohno Y., Itakura A., Sano M., et al. Pure red cell aplasia and acute hepatitis during pregnancy. Gynecol Obstet Invest. 53:2002;112-113.
50. Okoshi Y., Imagawa S., Higuchi M., et al. A patient with acquired pure red cell aplasia showing a positive antiglobulin test and the presence of inhibitor against erythroid precursors. Intern M. 41:2002;589-592.
51. Orbach H., Ben-Yehuda A., ben-Yehuda D., et al. Successful treatment of pure red cell aplasia in systemic lupus erythematosus with erythropoietin. J Rheumatol. 22:1995;2166-2169.
52. Paltiel O., Cournoyer D., Rybka W. Pure red cell aplasia following ABO-incompatible bone marrow transplantation: response to erythropoietin. Transfusion. 33:1993;418-421.
53. Picot C., Triadou P., Lacombe C., et al. Relapsing pure red cell aplasia during pregnancy. New Engl J M. 311:1984;196.
54. Poullis M., Punjabi P. Concomitant thymectomy and cardiac operation in a patient with pure red cell aplasia. Ann Thorac Surg. 72:2001;621-623.
55. Prabhakar S.S., Muhlfelder T. Antibodies against human erythropoietin causing pure red cell aplasia. Clin Nephrol. 47:1997;331-335.
56. Reid T.J. 3rd, Mullaney M., Burrell L.M., et al. Pure red cell aplasia after chemotherapy for Hodgkin's lymphoma: in vitro evidence for T cell mediated suppression of erythropoiesis and response to sequential cyclosporin and erythropoietin. Am J Hematol. 46:1994;48-53.
57. Santamaria A., Sureda A., Martino R., et al. Successful treatment of pure red cell aplasia after major ABO-incompatible T-cell depleted bone marrow transplantation with erythropoietin. Bone Marrow Transplant. 20:1997;1105-1107.
58. Sharma R.A., Hiwarkar P., Manglani M.V., et al. Acquired pure red cell aplasia in a child. J Postgrad M. 48:2002;37-38.
59. Sharma V.R., Fleming D.R., Slone S.P. Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab. Blood. 96:2000;1184-1186.
60. Singh V.P., Khanna A., Rai M., et al. Non-Hodgkin's lymphoma with pure red cell aplasia. J Assoc Physicians India. 49:2001;1123-1124.
61. Song K.W., Mollee P., Patterson B., et al. Pure red cell aplasia due to parvovirus following treatment with CHOP and rituximab for B-cell lymphoma. Br J Haematol. 119:2002;125-127.
62. Tomit N., Motomura S., Ishigatsubo Y. Interferon-alpha-induced pure red cell aplasia following chronic myelogeneous leukemia. Anticancer Drugs. 12:2001;7-8.
63. Veelken H., Wasch R., Behringer D., et al. Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning. Bone Marrow Transplant. 26:2000;911-915.
64. Viallard J.F., Parrens M., Hermine O., et al. Severe prolonged blood cell aplasia and thrombocytopenia induced by parvovirus infection B19 infection in a patient with sarcoidosis. Clin Infect Dis. 36:2003;229-233.
65. Weber G., Gross J., Kromminga A., et al. Allergic skin and systemic reactions in a patient with pure red cell aplasia and anti-erythropoietin antibodies challenged with different epoietins. J Am Soc Nephrol. 13:2002;2381-2383.
66. Winkelmann J.C. The human erythropoietin receptor. Int J Cell Cloning. 1992;254-261.
67. Yamauchi T., Shirasaki H., Kuwata A., et al. Pure red cell aplasia developing into myeloproliferation with myelodysplasia and subsequent leukemia after cyclosporin A therapy. Int J Hematol. 75:2002;514-518.
68. Yang M.H., Hau H.C. Pure red cell aplasia after ABO-incompatible allogeneic stem cell transplantation in severe aplastic anemia with response to steroids: a case report and literature review. Ann Hematol. 80:2001;299-301.
69. Zecca M., De-Stefano P., Nobill B., et al. Anti-CD20 monoclonal antibody for treatment of severe, immune-mediated pure red cell aplasia and hemolytic anemia. Blood. 97:2001;3995-3997.
70. Zeigler Z.R., Rosenfeld C.S., Shadduck R.K. Resolution of transfusion dependence by human recombinant erythropoietin (rHuEPO) in acquired pure red cell aplasia (PRCA) associated with myeloid metaplasia. Br J Haematol. 83:1993;28-29.
71. Zhu K.E., Xu Y., Wu D., et al. Pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 10:2002;61-65.
72. Zeidman A., Fradin Z., Barac Y., et al. Splenic lymphoma presenting as warm autoimmune hemolytic anemia associated with pure red cell aplasia. Vox Sang. 78:2000;126-129.